Viriome

The HCV Inhibitor Machine
Home
About Us
Leadership
Click Chemistry
HCV Lifecycle Assay
HCV Inhibitors
Business Development
Contact Us
Site Map
Business Development
 
Seeking partners for further development and commercialization of HCV inhibitor
 
  • Flexible on deal structure and terms

 

  • Eager to maximize potential of drugs
 
 
Seeking investment to maximize assset
 
  • Tremendous partnering interest
  • But early deals unlikely to provide sufficient near term revenue to maximize Viriome's opportunities quickly
  • Funding would enable Viriome's continued exploraton of additional inhibitors (in parallel with partnered assets)